Double Duty: Creating Trials To Satisfy Both FDA And CMS

Firms can do "double duty" by gathering economic data during their FDA pivotal trials to get a jump start on CMS coverage, according to Abbott Diagnostic's Barbara Calvert, director of medical products reimbursement

More from Archive

More from Medtech Insight